Source: Annual Congress 2011 - COPD management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Díez-Manglano, J. Barquero-Romero, P. Almagro-Mena, J. B. Soriano, J. Recio-Iglesias, F. J. Cabrera-Aguilar, ECCO Study Investigators (Zaragoza, Badajoz, Tarrasa, Barcelona, Madrid, Bunyola, Mallorca, Spain). Polypharmacy in patients with acute exacerbation of COPD. Eur Respir J 2011; 38: Suppl. 55, 540

Member's Comments

No comment yet.

Related content which might interest you: Polypharmacy in patients hospitalised for acute exacerbation of COPD Source: Eur Respir J 2014; 44: 791-794 Year: 2014 Rehospitalizations for an acute exacerbation among patients with COPD Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Anemia in COPD patients with an exacerbation Source: Annual Congress 2011 - COPD exacerbation Year: 2011 The rationality of the use of NIV in elderly patients with acute COPD exacerbation Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure Year: 2018 COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis Source: International Congress 2016 – Dealing with the complexity of critically-ill patients Year: 2016 Cognitive impairment in patients hospitalized with acute COPD exacerbation Source: International Congress 2014 – Physical activity, exercise and physiotherapy in COPD and asthma Year: 2014 β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Quantification of severity of the acute exacerbation in hospitalized COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 559s Year: 2003 High-risk patients following hospitalisation for an acute exacerbation of COPD Source: Eur Respir J 2013; 42: 946-955 Year: 2013 Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD Source: Eur Respir J 2013; 41: 993-995 Year: 2013 Influence of bronchiectasis in patients hospitalized due to acute exacerbation of COPD. Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 The validity of the EQ5D5L in patients hospitalized an acute exacerbation of COPD Source: International Congress 2017 – Latest insights into chronic care Year: 2017 Antibiotics in acute exacerbation of asthma and COPD Source: Eur Respir Monogr 2017; 75: 150-158 Year: 2017 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Gender differences in hospitalized patients with acute exacerbation of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Determinants of re-hospitalizations due to acute exacerbation of COPD Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 Prognosis after hospitalization for acute exacerbations of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 209s Year: 2001 NIV in COPD: acute exacerbation and beyond Source: ERS course 2015 Year: 2015 Cost analysis for inpatient therapy in elderly patients with acute exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 661s Year: 2004 Management of acute COPD exacerbations Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention Year: 2013